Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study
10/14/2011
More...
|
Old Osteoporosis Drug May Help In Killing Flu Viruses, University of Hong Kong Study
6/29/2011
More...
|
One in Five Heart Attack Deaths Could be Prevented with New Drug, University of Sheffield Study
6/14/2011
More...
|
Viagra Could Reduce Multiple Sclerosis Symptoms, Autonoma de Barcelona Study
5/20/2011
More...
|
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study
5/2/2011
More...
|
Diabetes Treatment May Also Provide Protection Against Endometrial Cancer, University of Warwick and Warwick Medical School Study
4/6/2011
More...
|
Infectious Diseases Society of America: Linezolid Wins Battle on MRSA Pneumonia, Pitie-Salpetriere Hospital Study
10/27/2010
More...
|
Boehringer Ingelheim Corporation, Pfizer Inc. (PFE)'s Spiriva Improves Asthma Treatment, Study Shows
9/22/2010
More...
|
Common Pain Relievers Raise Heart Risk for Healthy Folks, Gentofte University Hospital Study
6/9/2010
More...
|
Common Cholesterol Drugs, Statins, Fight Cataracts, Too, Tel Aviv University Study
2/12/2010
More...
|
Switching Immunosuppressants Reduces Cancer Risk In Kidney, Queen Elizabeth Hospital Study
11/2/2009
More...
|
Combination Antiretroviral Therapy Effective At Reducing HIV Resistance In Mothers And Babies Following Mother-to-child Transmission, Study Funded by Boehringer Ingelheim Corporation
10/28/2009
More...
|
Rheumatoid Arthritis Biologics Increase Risk of Common Skin Cancer, University of Manchester Study
10/19/2009
More...
|
Bowel Disease Drugs Increase Cancer Risk, Saint-Antoine Hospital Study
10/19/2009
More...
|
Older Antidepressant Spurs More Suicidal Thinking In Men Than Newer Medication, King's College London Study
10/16/2009
More...
|
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1
5/21/2013
More...
|
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism
2/21/2013
More...
|
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS
12/13/2012
More...
|
Celgene International Sárl (CELG) Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting
12/11/2012
More...
|
Celgene (CELG) Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia
12/11/2012
More...
|
Boehringer Ingelheim Corporation Release: Treatment With Pradaxa® Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin
12/10/2012
More...
|
AstraZeneca PLC (AZN) Release: Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX® (fulvestrant) Injection 500 mg Compared With 250 mg.1,2
12/5/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients
11/15/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet Regimen Stribild™ Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naive HIV Patients
11/15/2012
More...
|
Boehringer Ingelheim Corporation Release: RELY-ABLE®: Unprecedented Long-Term Data Support Safety Profile and Sustained Efficacy of Pradaxa® for Stroke Prevention in AF
11/8/2012
More...
|
Boehringer Ingelheim Corporation Release: Recruitment Complete for Trajenta ® (linagliptin) Cardiovascular Outcome Study in Patients With Type 2 Diabetes
11/8/2012
More...
|
Boehringer Ingelheim Corporation Release: Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement
11/6/2012
More...
|
Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation
11/5/2012
More...
|
Wealth of Worldwide Evidence on Boehringer Ingelheim GmbH's Pradaxa® Including First Clinical Data on Long-Term Efficacy and Safety of a Novel Oral Anticoagulant to be Presented at American Heart Association Scientific Sessions
10/31/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People With Relapsing Forms of MS
10/11/2012
More...
|